Clinical Trials Directory

Trials / Completed

CompletedNCT07256431

Environmental Risk Factors in Multiple Sclerosis Development: Epidemiological Study of EBV Infection and Vitamin D Deficiency in RIS Patients

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is an ancillary study using samples collected in the ProBioRIS cohort (NCT06395662). The aim of the project is to highlight new biomarker candidates to assess the risk of conversion to clinically definite multiple sclerosis (CDMS) and disease activity (Evidence of Disease Activity) by taking into account demographic, clinical and MRI parameters. A cohort of healthy subjects will be integrated into the study to serve as a control population. We will study a panel of serum immunoglobulins targeting different Epstein Barr virus antigens to identify latency or reactivation phases. Identifying and prioritizing risk factors for clinical conversion to MS in radiologically isolated syndrome patients is of major importance for the implementation of personalized monitoring and treatment strategies, especially following the recent highlighting of the benefit of background treatments in patients at high risk of CDMS.

Conditions

Interventions

TypeNameDescription
OTHERAntibiody titrationSearch for EBV seropositivity using SIMAO assay

Timeline

Start date
2023-08-01
Primary completion
2024-07-30
Completion
2024-07-30
First posted
2025-12-01
Last updated
2025-12-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07256431. Inclusion in this directory is not an endorsement.